Clinical Trial: PET Imaging of Noradrenergic Transmission in the Brain

U.S., July 8 -- ClinicalTrials.gov registry received information related to the study (NCT07686393) titled 'PET Imaging of Noradrenergic Transmission in the Brain' on July 03.

Brief Summary: Background:

Researchers have developed a new radioactive tracer (11C-ARMI). A tracer is a drug that attaches itself to other chemicals in the body and lights up so that the chemicals can be seen in imaging scans. The new tracer may be able to help them with many diseases, such as Alzheimer s disease and Parkinson s disease. Researchers want to test the new tracer in healthy people.

Objective:

To test a new tracer (11C-ARMI) during imaging scans of the brain and body in healthy people.

Eligibility:

Healthy people aged 18 years and older. They must ...